Aishwarya Gondane
Pl 63
Helsinki, 00014, Finland
Helsinki, 00014, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
CDK12/13 Inhibition Induces DNA Hypomethylation and Sensitizes Cancer Cells to Compounds Targeting DNA-PK.
Journal: Journal of cellular and molecular medicine
Published: March 24, 2026
Inactivation of CDK12 Enhances Mitochondrial Efficiency to Suppress DNA Damage.
Journal: Journal of cellular and molecular medicine
Published: September 14, 2025
Dynamic O-GlcNAcylation and phosphorylation attract and expel proteins from RNA polymerase II to regulate mRNA maturation.
Journal: Journal of biomedical science
Published: December 10, 2024
Altered behaviour and immune response in mice with NHLRC2 p.Asp148Tyr variant.
Journal: Brain, behavior, & immunity - health
Published: September 16, 2024
Compromised CDK12 activity causes dependency on the high activity of O-GlcNAc transferase.
Journal: Glycobiology
Published: April 01, 2024
CDK12-inactivation-induced MYC signaling causes dependency on the splicing kinase SRPK1.
Journal: Molecular oncology
Published: October 11, 2023
Revealing the History and Mystery of RNA-Seq.
Journal: Current issues in molecular biology
Published: January 23, 2023
Castration-resistant prostate cancer cells are dependent on the high activity of CDK7.
Journal: Journal of cancer research and clinical oncology
Published: September 04, 2022
O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition.
Journal: Glycobiology
Published: April 11, 2022
O-GlcNAc transferase couples MRE11 to transcriptionally active chromatin to suppress DNA damage.
Journal: Journal of biomedical science
Published: October 25, 2021
Inhibition of CDK9 activity compromises global splicing in prostate cancer cells.
Journal: RNA biology
Published: October 01, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026